AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06315114 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Care as usual (CAU)
Description: 1-2 next of kin sessions (called 'Familiesamtale') is considered the care as usual offered to parents in adult mental health service in the Capital Region of Denmark.~Parents are offered the possibility of bringing their spouse or offspring to one of the sessions.
Study NCT05680324 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Monsplasty
Description: liposuction assisted monsplasty
Study NCT06509490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KD-025 cell injection
Description: This is an open-label, dose escalation/expansion study to assess the safety, tolerability, and efficacy of KD-025 cell infusion in patients with advanced NKG2DL+ solid tumor. In this study,the enrollment of the patients must meet the inclusion and exclusion criteria . All subjects will be undergo screening, pre-treatment (cell product preparation;lymphodepleting chemotherapy), treatment and follow up
Study NCT06534827 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Great Life Mentoring
Description: The Great Life Mentoring program (GLM) provides volunteer-based mentoring for school-age youth from low-resource families who are receiving outpatient mental health care. Each youth is paired with a mentor with whom they spend time in the community on a weekly basis for at least one year. Mentors are required to complete a 20-hour intensive training prior to being paired with a youth. Mentors also receive monthly in-person supervision from GLM staff for the first year of their meetings, which continues on an as-needed basis thereafter. Training and supervision are geared toward the unique opportunities and challenges that can occur when mentoring a youth with mental health needs. The goal is for the mentor to become an integral part of the child's mental health treatment, but the mentoring relationship is also sustained after treatment ends.
Study NCT05239598 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Mouth rinse
Description: Subjects will be asked to rinse/gargle one time with 10 mL of assigned mouth rinse for 30 seconds.
Study NCT05239598 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mouth rinse
Description: Subjects will be asked to rinse/gargle one time with 10 mL of assigned mouth rinse for 30 seconds.
Study NCT06479525 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Big Toe Flexor Strengthening Exercises
Description: 16 participants will be in experimental group A giving them Big Toe Flexor strengthening exercise protocol along with the sports training plan for eight weeks measuring all values before giving them protocol and after protocol.
Study NCT06479525 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Calf Strengthening Exercises
Description: 16 participants will be in experimental group B giving them calf strengthening exercises including towel curls and thera band exercises along with the sports training plan for eight weeks measuring all values before giving them protocol and after protocol.
Study NCT05849506 — intervention group
Intervention type: DEVICE
Intervention: Touch® Prosthesis
Description: The Touch® prosthesis is a medical device approved in Switzerland, which is an effective surgical treatment for advanced CMC I osteoarthritis.
Study NCT04695821 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Senti V1.0 Device
Description: This device class I, CE marked garment, with a similar form to a T-Shirt, embedded with ten sensor modules encased in silicone; the device comes with a charging stand in the form of a clothes hanger. Depending on the outcome of this feasibility study, the device may, in the future, form part of a class IIb medical device system, when accompanied by cloud-based software to listen to both current and historically recorded breath sounds for each Senti patient. The Senti Version One device will be labelled clearly to indicate the device version, on the inside of the garment, conforming to the MDR.~The garment itself will be made from textile composite, including cotton, elastase, micromodel, spandex, and polyester. All other components (including electronic and other plastic components) will be entirely encased in medical-grade silicone.
Study NCT05758272 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mobile phone-based simple physical exercise reminder to help quit smoking
Description: Regular messages supporting participants in practicing simple physical exercises and assist in managing cravings will be sent to participants via IM apps and scheduled in a tapering manner for 3 months (twice per week in the first month to once per week in the third month). Images and videos explaining and demonstrating the simple physical exercises will be sent to the participants via IM apps, which serves as a reminder and supporting materials for participants. The benefits of exercise in SC will be explained. The investigator will also encourage the practice of moderate/ vigorous exercises to further improve the physical activity and well-being of the participants. Various delivery formats of messages will be considered to attract participants' interest such as text, emojis, voice, image, animation, and video. The simple exercises consist of a) Zero-time exercises (ZTEx), b) handgrip exercises and c) resistance exercises.
Study NCT05758272 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: regular text-based intervention
Description: The control group will receive 6 regular messages via IM at twice per month within 3 months. These messages cover simple cessation advice and reminders for telephone follow-ups.
Study NCT05413122 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Varenicline
Description: At enrolment, a 12-week course of varenicline in the commercially available package will be dispensed by a study clinician.
Study NCT06260241 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Traction Dressing
Description: Traction dressing will be applied to one group for 24 hours and simple dressing to the other group.
Study NCT06260241 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Without Traction Dressing
Description: Without Traction Dressing
Study NCT05218746 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block
Description: High-frequency linear transducer will be placed on the patient's midaxillary line in the transverse plane, at the level of the fifth rib, with the indicator oriented toward the operator's left. With the rib, pleural line, and overlying serratus anterior and latissimus dorsi muscles visualized, Then, using ultrasound guidance, the needle will be advanced in-plane at an angle of approximately 45 degrees towards the fifth rib . one millileter normal saline will be injected to confirm placement and to hydro-dissect the fascial layers and open the potential space.
Study NCT05218746 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Erector spinae block
Description: A high-frequency linear ultrasound probe will be placed in a longitudinal orientation 3 cm from the midline. Once the erector spinae muscle and the transverse processes is identified, spinal needle will be inserted in a caudad-to-cephalad direction until the tip lay in the interfacial plane deep to the erector spinae muscle.
Study NCT06201871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine Hydrochloride
Description: Patients will receive an inferior alveolar nerve block injection using 1.8 mL of 2% lidocaine with 1: 80 000 epinephrine using a direct Halsted approach.
Study NCT06201871 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine Hydrochloride
Description: Patients will receive an inferior alveolar nerve block injection using 1.8 mL of 2% lidocaine with 1: 80 000 epinephrine using a direct Halsted approach.
Study NCT05698329 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AIV007
Description: Periocular injection
Study NCT05528822 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ultrasound-guided high fascia iliaca compartment block
Description: H-FICB was guided by ultrasound before general anesthesia. The patient was supine. First, the probe is placed transversely above the groin. Then slide the probe up and down to reveal a clear image of the internal oblique and sartorius muscles. There is a bowtie-like iliac fascia space at the junction of these two muscles. After the scanning, the needle was inserted behind the probe with the tip pointed to the ventral side under the guidance of real-time ultrasound; the tip passed through the skin into the iliac fascia space and advanced to the inguinal ligament. After no blood was extracted, 1 \~ 2 ml of normal saline was firstly injected to determine whether the tip position was correct. If the needle tip was correctly positioned, 0.375% ropivacaine 30 mL of local anesthetic was injected. The H-FICB was performed under ultrasound guidance by the same anesthesiologist.
Study NCT05528822 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ultrasound-guided pericapsular nerve group (PENG) block
Description: A low-frequency curvilinear transducer was placed in the transverse plane over the anterior inferior iliac spine (AIIS) and moved over inferiorly to visualize the pubic ramus. The femoral artery and ilio pubic eminence (IPE) were then visualized (Figure 1). Using in-plane technique 10 cm echogenic 21 gauge needle was advanced from lateral to medial direction, and 20 ml of local anesthetic 0.5% ropivacaine was deposited between the psoas tendon anteriorly and pubic ramus posteriorly.
Study NCT05606198 — intervention group
Intervention type: OTHER
Intervention: Exposed to a SARS-CoV-2 infection
Description: The study compared humans exposed to the SARS-CoV-2 infection with a matched group of those not exposed. No Intervention was applied.
Study NCT04797598 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virtual reality group
Description: This will receive Virtual reality sessions and both group will receive conventional physical therapy as base line treatment
Study NCT04797598 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cyclic training group
Description: This will receive cyclic training session. both group will receive conventional physical therapy as base line treatment
Study NCT04764201 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: HIP2001
Description: Test drug
Study NCT04764201 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: HGP2001
Description: Reference drug
Study NCT05431998 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: the use of demineralized autogenous tooth graft in the jumping gap during immediate implant placement
Description: the use of demineralized autogenous tooth graft in the jumping gap during immediate implant placement
Study NCT05431998 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: the use of autogenous bone graft in the jumping gap during immediate implant placement
Description: the use of autogenous bone graft in the jumping gap during immediate implant placement
Study NCT04732247 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxytocin nasal spray
Description: Intranasal treatment with oxytocin via nasal spray (48 IU per dose)
Study NCT04732247 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo nasal spray
Description: Intranasal treatment with placebo via nasal spray
Study NCT06426095 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group A (instructional video),
Description: Participants in Group A received access to a specially prepared pre-recorded instructional video detailing the step-by-step process of porcelain-fused-to-metal tooth preparation for molars.
Study NCT06426095 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group B (live demonstration)
Description: Participants in Group B were provided with live demonstrations of the same procedure conducted by the same experienced Prosthodontist to ensure consistency in teaching quality and technique
Study NCT06426095 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group C (hybrid)
Description: Group C received a dual approach, combining instructional video guidance with live demonstrations.
Study NCT05376878 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Copper Cu 64-DOTA-Trastuzumab
Description: Given IV
Study NCT05376878 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo PET/MRI
Study NCT05376878 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/MRI
Study NCT05376878 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: Given IV
Study NCT05376878 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trastuzumab Deruxtecan
Description: Given IV
Study NCT05603897 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mann Assessment of Swallowing Ability (MASA) (dysphagia screening tool)
Description: Upon 1-2 days of admission to inpatient rehabilitation, the MASA will be administered for approximately 20 minutes during initial speech language pathology evaluation. The MASA will be administered at bedside as a cognitive/speech language evaluation as well as oropharyngeal function examination.
Study NCT05603897 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Non-standardized clinical swallow evaluation
Description: Participants will receive current standard of care for dysphagia screening and treatment.
Study NCT05425407 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: whey protein
Description: Daily 45g of whey protein supplementation during a three week eccentric training period
Study NCT05425407 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: whey protein + collagen peptide
Description: Daily 15g of whey protein and 20g collagen peptide supplementation during a three week eccentric training period
Study NCT05271318 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TILT-123
Description: Tumor necrosis factor alpha (TNFalpha) and Interleukin-2 (IL-2) coding oncolytic adenovirus TILT-123
Study NCT05271318 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: pembrolizumab
Description: pembrolizumab, a monoclonal antibody binding PD-1
Study NCT05271318 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pegylated liposomal doxorubicin
Description: Pegylated Liposomal Doxorubicin is a chemotherapy and a pegylated liposomal form of the anthracycline topoisomerase inhibitor, doxorubicin.
Study NCT05413122 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Description: A 12-week course of nicotine patches and nicotine gum will be dispensed to the participant by the counsellor according to randomization into the c-NRT condition. c-NRT will be provided per label instructions given number of cigarettes the participant smokes per day and will be provided in the commercially available package.
Study NCT05187247 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality glasses
Description: use of virtual reality glasses to reduce anxiety and pain levels
Study NCT04173702 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: balance analysis
Description: Computerized balance analysis system will use to evaluate postural sway and limits of stability at four different support surfaces.
Study NCT05821686 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Human Interleukin-2 (IL-2) (Proleukin)
Description: All the recruited participants will receive 4 intralesional injections of Interleukin-2 with a dose of 500,000 international units (IU) per mm width of tumor to max dose of 10 million IU.
Study NCT04151472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo oral tablet, three times a day
Study NCT04151472 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo oral tablet, three times a day
Study NCT04151472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 90mg Idebenone
Description: Idebenone 30 MG Oral Tablet, three times a day
Study NCT04151472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 270mg Idebenone
Description: Idebenone 90 MG Oral Tablet, three times a day
Study NCT06014502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMGS-001
Description: Every 2 weeks
Study NCT05197114 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: summerlunch+ At Home Food Skills Program
Description: The summerlunch+ At Home program a virtual eight-week food skills program that teaches cooking, nutrition and environmental sustainability to children. The program has been adapted for those with Type 1 Diabetes to teach important food skills specific to diabetes management.
Study NCT05154240 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: INS018_055
Description: INS018_055 is a small molecule compound. INS018_055 has good solubility in water and was chemically and physically stable at different temperatures.
Study NCT05154240 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05560750 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Frenotomy
Description: Releasing the tongue-tie with scissors
Study NCT05560750 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Oral physiotherapy
Description: Gentle parental activation of the mouth area and the tongue for 1 month
Study NCT04874623 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Collection of peripheral blood mononuclear cells
Description: Analysis of specific memory B cells in CDI patients
Study NCT05001997 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Lactose free probiotic yogurt
Description: Probiotics are non-pathogenic, live microbes that when eaten or administered In adequate amount, it confer health benefits to host. Only lactose free probiotic yogurt containing cultures such as Lactobacillus acidophilus and Bifidobacterium lactis will be selected.
Study NCT05001997 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Lactose free probiotic yogurt
Description: Probiotics are non-pathogenic, live microbes that when eaten or administered In adequate amount, it confer health benefits to host. Only lactose free probiotic yogurt containing cultures such as Lactobacillus acidophilus and Bifidobacterium lactis will be selected.
Study NCT05168709 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tozinameran
Description: Tozinameran is a single-stranded, 5'-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Study NCT04031573 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivabradine
Description: Ivabradine will be administered via the enteral route, every 12 hours, at doses ranging from 2.5 to 5 mg to achieve a target heart rate between 80 and 94 bpm
Study NCT04031573 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivabradine
Description: Ivabradine will be administered via the enteral route, every 12 hours, at doses ranging from 5 to 7.5 mg to achieve a target heart rate between 80 and 94
Study NCT04031573 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered via the enteral route, every 12 hours.
Study NCT05195892 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A
Description: Single oral dose of alpelisib film-coated tablet at 50 mg in fed state
Study NCT05195892 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B
Description: Single oral dose of alpelisib granule at 50 mg in fed state
Study NCT05195892 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C
Description: Single oral dose of alpelisib granule at 50 mg in fasted state
Study NCT05413122 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine gum
Description: A 12-week course of nicotine patches and nicotine gum will be dispensed to the participant by the counsellor according to randomization into the c-NRT condition. c-NRT will be provided per label instructions given number of cigarettes the participant smokes per day and will be provided in the commercially available package.
Study NCT05887206 — intervention group
Intervention type: OTHER
Intervention: Collection of datas
Description: The collected data are : sex, age, date of first immunotherapy cycle, dose, date of first consultation, objective refraction in spheric equivalent, keratometry, visual acuity, microcyst-like epithelial changes (MECs), location and density, corneal toxicity grade and complementary exams (topography, in vivo confocal microscopy).
Study NCT06242704 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Working Memory Training
Description: A multi-session computer-based working memory training program to improve delay discounting and prevent substance use among at-risk adolescents in a traditionally underserved area.
Study NCT06242704 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Working Memory
Description: A multi-session control computer training condition that is designed to not engage working memory among at-risk adolescents in a traditionally underserved area.
Study NCT04314388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention: Outdoor Walking Rehabilitation Programme
Description: Participants in the intervention group will take part in an instructor led outdoor walking rehabilitation programme which will last for 3 months. Alongside this participants will also be asked to complete a home exercise programme.
Study NCT04314388 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control: The light Stretches Programme
Description: Participants in the control group will be asked to keep to their normal activities of daily living, and given 10 targeted active stretches of the upper and lower body.